# Triptorelin Pamoate (Trelstar)

Source: https://ourhealthnetwork.com/drugs/triptorelin-pamoate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Triptorelin Pamoate?

Triptorelin Pamoate (brand name: Trelstar) is a gonadotropin-releasing hormone (gnrh) agonist. It is prescribed to treat prostatic neoplasms. Across the United States, 110 doctors prescribe Triptorelin to approximately 1,000 Medicare patients.

## Brand names

Trelstar

## Indications

Triptorelin Pamoate is primarily prescribed for the treatment of prostatic neoplasms.

## Conditions treated

- [Prostatic Neoplasms](https://ourhealthnetwork.com/conditions/prostatic-neoplasms)

## Mechanism of action

Triptorelin is a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). Comparative in vitro studies showed that triptorelin was 100-fold more active than native GnRH in stimulating luteinizing hormone release from monolayers of dispersed rat pituitary cells in culture and 20-fold more active than native GnRH in displacing 125 I-GnRH from pituitary receptor sites.

## Drug classification

- Established Pharmacologic Class: gonadotropin-releasing hormone (GnRH) agonists

## Common side effects

headache

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)